Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

Transcaval Access for Transcatheter Aortic Valve Replacement in People With No Good Options for Aortic Access

ClinicalTrials.gov ID: NCT02280824

Public ClinicalTrials.gov record NCT02280824. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 12:53 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Transcaval Access for Transcatheter Aortic Valve Replacement in Patients With No Good Options for Aortic Access

Study identification

NCT ID
NCT02280824
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Enrollment
172 participants

Conditions and interventions

Interventions

  • CA-TAVR Procedure
  • Amplatzer Duct Occluder Device

Procedure · Device

Eligibility (public fields only)

Age range
21 Years to 99 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 29, 2014
Primary completion
Jul 26, 2017
Completion
Dec 27, 2018
Last update posted
Feb 14, 2019

2014 – 2018

United States locations

U.S. sites
15
U.S. states
10
U.S. cities
15
Facility City State ZIP Site status
Medstar Washington Hospital Center Washington D.C. District of Columbia 20010
Emory University Atlanta Georgia 30322-1102
NorthShore University HealthSystem, Evanston Hospital Evanston Illinois 60201
Advocate Heart Institute Oakbrook Terrace Illinois 60181
Cardiovascular Institute of the South Houma Louisiana 70360
Ochsner Health System New Orleans Louisiana 70121
Henry Ford Hospital Detroit Michigan 48202
Wake Forest University Winston-Salem North Carolina 27103
Oklahoma Heart Institute Tulsa Oklahoma 74104
York Hospital York Pennsylvania 17403
Vanderbilt Heart and Vascular Institute Nashville Tennessee 37232
University of Virginia Medical Center Charlottesville Virginia 22908
INOVA Fairfax Hospital Falls Church Virginia 22042
Sentara Norfolk General Hospital Norfolk Virginia 23507
Carilion Medical Center Roanoke Virginia 24014

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02280824, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 14, 2019 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02280824 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →